Matrine induces the apoptosis of lung cancer cells through downregulation of inhibitor of apoptosis proteins and the Akt signaling pathway

Oncology Reports

Volumn 32, Issue 3, 2014, Pages 1087-1093

  Niu, Huiyan ^a   Zhang, Yifei ^a   Wu, Baogang ^a   Zhang, Yi ^a   Jiang, Hongfang ^a   He, Ping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Inhibitors of apoptosis proteins; Lung cancer; Matrine; Phosphatidylinositol 3 kinase Akt mammalian target of rapamycin

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MATRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ALKALOID; ANTINEOPLASTIC AGENT; QUINOLIZINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; IN VITRO STUDY; LUNG CANCER; LUNG CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; DRUG EFFECTS; HUMAN; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ALKALOIDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; QUINOLIZINES; SIGNAL TRANSDUCTION;

EID: 84907296967     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3273     Document Type: Article

References (52)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83: 584-594, 2008. (Pubitemid 351720831)
3. Zhang Y, Zhang H, Yu P, et al: Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology 59: 191-200, 2009.
4. Efferth T, Konkimalla VB, Wang YF, et al: Prediction of broad spectrum resistance of tumors towards anticancer drugs. Clin Cancer Res 14: 2405-2412, 2008. (Pubitemid 351551074)
5. Dong J, Su SY, Wang MY and Zhan Z: Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review. J Exp Clin Cancer Res 29: 137, 2010.
6. Liu XS, Jiang J, Jiao XY, Wu YE and Lin JH: Matrine-induced apoptosis in leukemia U937 cells: involvement of caspases activation and MAPK-independent pathways. Planta Med 72: 501-506, 2006. (Pubitemid 43844676)
7. Zhang HM and Li HQ: Anti-arrhythmic effects of sophoridine and oxysophoridine. Zhongguo Yao Li Xue Bao 20: 517-520, 1999.
8. 2+]i in guinea pig ventricular myocytes. Acta Pharmacol Sin 22: 512-515, 2001.
9. Xu CQ, Dong DL, Du ZM, Chen QW, Gong DM and Yang BF: Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866. Yao Xue Xue Bao 39: 691-694, 2004 (In Chinese).
10. Hu ZL, Zhang JP, Yu XB, Lin W, Qian DH and Wan MB: Effect of matrine on lipopolysaccharides/D-galactosamine-induced hepatitis and tumor necrosis factor release from macrophages in vitro. Zhongguo Yao Li Xue Bao 17: 351-353, 1996 (In Chinese). (Pubitemid 26291061)
11. Liu J, Zhu M, Shi R and Yang M: Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials. Am J Chin Med 31: 337-354, 2003. (Pubitemid 41758821)
12. Long Y, Lin XT, Zeng KL and Zhang L: Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. Hepatobiliary Pancreat Dis Int 3: 69-72, 2004. (Pubitemid 38256128)
13. Gao HY, Li GY, Lou MM, Li XY, Wei XY and Wang JH: Hepatoprotective effect of matrine salvianolic acid B salt on carbon tetrachloride-induced hepatic fibrosis. J Inflamm 9: 16, 2012.
14. Liu JY, Hu JH, Zhu QG, Li FQ, Wang J and Sun HJ: Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts. Int Immunopharmacol 7: 816-823, 2007. (Pubitemid 46635279)
15. Li H, Tan G, Jiang X, et al: Therapeutic effects of matrine on primary and metastatic breast cancer. Am J Chin Med 38: 1115-1130, 2010.
16. Li LQ, Li XL, Wang L, et al: Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell Physiol Biochem 30: 631-641, 2012.
17. Liu T, Song Y, Chen H, Pan S and Sun X: Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biol Pharm Bull 33: 1740-1745, 2010.
18. Luo C, Zhong HJ, Zhu LM, et al: Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism. Mol Biol Rep 39: 5459-5464, 2012.
19. Yang CL, Liu SS, Ma YG, Liu YY, Xue YX and Huang B: The influence of intraoperative pleural perfusion with matrine-cisplatin or cisplatin on stromal cell-derived factor-1 in non-small cell lung cancer patients with subclinical pleural metastasis. Med Oncol 29: 574-581, 2012.
20. Zhang J, Li Y, Chen X, et al: Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncol Rep 26: 115-124, 2011.
21. Chui CH, Lau FY, Tang JC, et al: Activities of fresh juice of Scutellaria barbata and warmed water extract of Radix Sophorae Tonkinensis on anti-proliferation and apoptosis of human cancer cell lines. Int J Mol Med 16: 337-341, 2005.
22. Hu MJ, Zeng H, Wu YL, et al: Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice. Chin J Dig Dis 6: 68-71, 2005. (Pubitemid 40936488)
23. Luo C, Zhu Y, Jiang T, et al: Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology 229: 245-252, 2007. (Pubitemid 44937494)
24. Ma L, Wen S, Zhan Y, He Y, Liu X and Jiang J: Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med 74: 245-251, 2008. (Pubitemid 351449946)
25. Yu P, Liu Q, Liu K, Yagasaki K, Wu E and Zhang G: Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology 59: 219-229, 2009.
26. Dai ZJ, Gao J, Ji ZZ, et al: Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol 123: 91-96, 2009.
27. Zhang S, Zhang Y, Zhuang Y, et al: Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PLoS One 7: e46853, 2012.
28. Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ and Tao HM: Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother Pharmacol 69: 317-331, 2012.
29. Jiang H, Hou C, Zhang S, et al: Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur J Pharmacol 559: 98-108, 2007. (Pubitemid 46295409)
30. Niu H, Li H, Xu C and He P: Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis. Oncol Rep 24: 465-471, 2010.
31. Niu H, Wang J, Li H and He P: Rapamycin potentiates cytotoxicity by docetaxel possibly through downregulation of survivin in lung cancer cells. J Exp Clin Cancer Res 30: 28, 2011.
32. Lu J, Luo Q, Cheng P, Liu X, Bai M and Tu M: The role of matrine and mitogen-ativated protein kinase/extracellular signal-regulated kinase signal transduction in the inhibition of the proliferation and migration of human umbilical veins endothelial cells induced by lung cancer cells. Zhongguo Fei Ai Za Zhi 12: 747-752, 2009 (In Chinese).
33. Chen Q, Liu L and Cao H: Effects of matrine on the growth inhibition, c-myc and hTERT protein expression in human adenocarcinoma lung cancer cell line A549. Zhongguo Fei Ai Za Zhi 11: 559-562, 2008 (In Chinese).
34. Nicholson KM and Anderson NG: The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395,2002. (Pubitemid 34214843)
35. Deveraux QL and Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 13: 239-252, 1999. (Pubitemid 29095796)
36. Hu S and Yang X: Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J Biol Chem 278: 10055-10060, 2003. (Pubitemid 36800260)
37. Altieri DC: The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7: 542-547, 2001.
38. Marioni G, Bertolin A, Giacomelli L, et al: Expression of the apoptosis inhibitor protein survivin in primary laryngeal carcinoma and cervical lymph node metastasis. Anticancer Res 26: 3813-3817, 2006. (Pubitemid 44701464)
39. Osaka E, Suzuki T, Osaka S, et al: Survivin as a prognostic factor for osteosarcoma patients. Acta Histochem Cytochem 39: 95-100, 2006.
40. Tran J, Rak J, Sheehan C, et al: Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264: 781-788, 1999.
41. Harfouche R, Hassessian HM, Guo Y, et al: Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res 64: 135-147, 2002. (Pubitemid 34713240)
42. Als AB, Dyrskjot L, von der Maase H, et al: Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer. Clin Cancer Res 13: 4407-4414, 2007. (Pubitemid 47219707)
43. Hinnis AR, Luckett JC and Walker RA: Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br J Cancer 96: 639-645, 2007.
44. Nakagawa Y, Abe S, Kurata M, et al: IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes. Am J Hematol 81: 824-831, 2006. (Pubitemid 44682183)
45. Watanuki-Miyauchi R, Kojima Y, Tsurumi H, et al: Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes. Pathol Int 55: 324-330, 2005. (Pubitemid 40910665)
46. Schlette EJ, Medeiros LJ, Goy A, Lai R and Rassidakis GZ: Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol 22: 1682-1688, 2004. (Pubitemid 41079807)
47. Adida C, Haioun C, Gaulard P, et al: Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96: 1921-1925, 2000. (Pubitemid 30661078)
48. Altieri DC: Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61-70, 2008.
49. Wang Y, Zhang Z, Garbow JR, et al: Chemoprevention of lung squamous cell carcinoma in mice by a mixture of Chinese herbs. Cancer Prev Res 2: 634-640, 2009.
50. Liu Y, Xu Y, Ji W, et al: Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol: Feb 14, 2014 (Epub ahead of print).
51. Linglu D, Yuxiang L, Yaqiong X, et al: Antinociceptive effect of matrine on vincristine-induced neuropathic pain model in mice. Neurol Sci: Dec 14, 2013 (Epub ahead of print).
52. Haiyan W, Yuxiang L, Linglu D, et al: Antinociceptive effects of matrine on neuropathic pain induced by chronic constriction injury. Pharm Biol 51: 844-850, 2013.